Add time:09/10/2019 Source:sciencedirect.com
α-Amidoboronic acids have received significant attention in recent years following the development of Bortezomib as an FDA-approved treatment of multiple myeloma and mantle cell lymphoma. More versatile methods to access α-amidoboronic acids continue to be developed. A direct method to access the precursors, α-amidoboronate esters, by iridium-catalyzed CH borylation of amides was developed using a readily available ligand/catalyst combination. Although the scope is limited, good yields of α-amidoboronate esters are achieved in high selectivity. Conversion of the boronate esters to the corresponding α-amidoboronic acids was also demonstrated.
We also recommend Trading Suppliers and Manufacturers of 6-Methyl-alpha-2-pyridyl-2-trifluoromethyl quinoline-4-methanol (cas 18709-90-5). Pls Click Website Link as below: cas 18709-90-5 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View